Adverse Events Following Immunization with Novel Oral Polio Vaccine Type 2, and the Experience and Challenges of Reporting in Sierra Leone [Response to Letter]

Drug Healthc Patient Saf. 2024 Sep 29:16:115-116. doi: 10.2147/DHPS.S496511. eCollection 2024.
No abstract available

Publication types

  • Comment